Xu W - Search Results

1

Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms.

Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK. Xu W, et al. EMBO J. 2007 Jun 20;26(12):2890-903. doi: 10.1038/sj.emboj.7601734. Epub 2007 May 24. EMBO J. 2007. PMID: 17525731 Free PMC article.

2

Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

Kasper LH, Boussouar F, Boyd K, Xu W, Biesen M, Rehg J, Baudino TA, Cleveland JL, Brindle PK. Kasper LH, et al. Among authors: xu w. EMBO J. 2005 Nov 16;24(22):3846-58. doi: 10.1038/sj.emboj.7600846. Epub 2005 Oct 20. EMBO J. 2005. PMID: 16237459 Free PMC article.

3

Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells.

Xu W, Fukuyama T, Ney PA, Wang D, Rehg J, Boyd K, van Deursen JM, Brindle PK. Xu W, et al. Blood. 2006 Jun 1;107(11):4407-16. doi: 10.1182/blood-2005-08-3263. Epub 2006 Jan 19. Blood. 2006. PMID: 16424387 Free PMC article.

4

Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.

Kasper LH, Fukuyama T, Lerach S, Chang Y, Xu W, Wu S, Boyd KL, Brindle PK. Kasper LH, et al. Among authors: xu w. PLoS One. 2013 Dec 10;8(12):e82684. doi: 10.1371/journal.pone.0082684. eCollection 2013. PLoS One. 2013. PMID: 24340053 Free PMC article.

5

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.

Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, Montminy M. Koo SH, et al. Among authors: xu w. Nature. 2005 Oct 20;437(7062):1109-11. doi: 10.1038/nature03967. Epub 2005 Sep 7. Nature. 2005. PMID: 16148943

6

Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.

Kang-Decker N, Tong C, Boussouar F, Baker DJ, Xu W, Leontovich AA, Taylor WR, Brindle PK, van Deursen JM. Kang-Decker N, et al. Among authors: xu w. Cancer Cell. 2004 Feb;5(2):177-89. doi: 10.1016/s1535-6108(04)00022-4. Cancer Cell. 2004. PMID: 14998493 Free article.

7

Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function.

Sun Y, Boyd K, Xu W, Ma J, Jackson CW, Fu A, Shillingford JM, Robinson GW, Hennighausen L, Hitzler JK, Ma Z, Morris SW. Sun Y, et al. Among authors: xu w. Mol Cell Biol. 2006 Aug;26(15):5809-26. doi: 10.1128/MCB.00024-06. Mol Cell Biol. 2006. PMID: 16847333 Free PMC article.

8

Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.

Sun Y, Fu A, Xu W, Chao JR, Moshiach S, Morris SW. Sun Y, et al. Among authors: xu w. J Physiol Biochem. 2015 Dec;71(4):807-21. doi: 10.1007/s13105-015-0445-5. Epub 2015 Nov 12. J Physiol Biochem. 2015. PMID: 26563351

9

MLF1 is a proapoptotic antagonist of HOP complex-mediated survival.

Sun Y, Chao JR, Xu W, Pourpak A, Boyd K, Moshiach S, Qi GY, Fu A, Shao HR, Pounds S, Morris SW. Sun Y, et al. Among authors: xu w. Biochim Biophys Acta Mol Cell Res. 2017 Apr;1864(4):719-727. doi: 10.1016/j.bbamcr.2017.01.016. Epub 2017 Jan 27. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28137643 Free article.

10

Synergistic Enhancement of Cathode Performance through the Introduction of Oxygen Vacancies in the P2/P3 Mixed Phase.

Qiu W, Jin B, Liu Z, Xu W, Zhang K, Hou Y, Lu J, Zhan X, Li Y, Zhang Q. Qiu W, et al. Among authors: xu w. ACS Appl Mater Interfaces. 2024 Dec 4. doi: 10.1021/acsami.4c14833. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 39629633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,992 results

Search Page

Filters